CRI, LRF Team Up to Improve How Doctors Assess Lymphoma Patients Treated with Immunotherapy November 30, 2016December 14, 2022 Arthur N. Brodsky, PhD
ASCO 2016 Update: Advances in Immunotherapy for Lung and Blood Cancers June 5, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Nivolumab (Opdivo) for Advanced Hodgkin Lymphoma Patients May 17, 2016December 14, 2022 Arthur N. Brodsky, PhD
CRI Partners with the Lymphoma Research Foundation to Improve Immunotherapy Evaluation Guidelines for Lymphoma December 11, 2015December 14, 2022 Arthur N. Brodsky, PhD
Two Immunotherapies Clear Important Regulatory Hurdles July 8, 2014December 14, 2022 Matthew Tontonoz